← Open Payments lookup

ROBERT WOLLENZIEN: Open Payments

NPI 1831674092 · SALEM, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,730 in 140 payments from 22 companies in 2025. Trend: 2023 $1,803 · 2024 $2,231 · 2025 $1,730

Food & beverage: $1,730
CompanyPaymentsAmount
ABBVIE INC.33$354
AstraZeneca Pharmaceuticals LP8$205
Astellas Pharma US Inc9$180
Novo Nordisk Inc21$177
Lilly USA, LLC26$125
Axsome Therapeutics, Inc.7$123
Otsuka America Pharmaceutical, Inc.7$104
GlaxoSmithKline, LLC.5$80
Bayer Healthcare Pharmaceuticals Inc.4$67
Novartis Pharmaceuticals Corporation3$61

Products named: Veozah, VRAYLAR, FARXIGA, REXULTI, MOUNJARO, Sunosi, UBRELVY, QULIPTA.

Industry payments across UT — which companies pay providers there.